Assessment of inhibitors with chromogenic substrates.
D000933:Antifibrinolytic Agents / Q000097:blood*; D002863:Chromogenic Compounds; D006801:Humans; D009842:Oligopeptides; D000979:alpha-2-Antiplasmin / Q000378:metabolism; D000511:alpha-Macroglobulins / Q000378:metabolism
D000933:Antifibrinolytic Agents; D002863:Chromogenic Compounds; D009842:Oligopeptides; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins; C018788:valyl-leucyl-lysine 4-nitroanilide